Samantha Lane
- Toxicology top 10%
- Pharmacovigilance and Adverse Drug Reactions 6
-
- SARS-CoV-2 and COVID-19 Research 7
- COVID-19 Clinical Research Studies 2
-
- Viral Infections and Immunology Research 3
-
- Heparin-Induced Thrombocytopenia and Thrombosis 3
-
- Drug-Induced Adverse Reactions 3
-
- Health Systems, Economic Evaluations, Quality of Life 2
- Pharmaceutical Economics and Policy 2
- Co-authors
- Saad ShakirAlison YeomansAlison EvansVicki OsborneDebabrata RoyRod StablesJosephine A. WrightPatrick McHugh
- Partner nations
- United KingdomUnited StatesNetherlands
In The Last Decade
Samantha Lane
19 papers receiving 180 citations
Peers
Comparison fields: 5 of 69
- Toxicology 22
- Infectious Diseases 97
- Applied Microbiology and Biotechnology 6
- Cardiology and Cardiovascular Medicine 45
- Critical Care and Intensive Care Medicine 7
Countries citing papers authored by Samantha Lane
This map shows the geographic impact of Samantha Lane's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Samantha Lane with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Samantha Lane more than expected).
Fields of papers citing papers by Samantha Lane
This network shows the impact of papers produced by Samantha Lane. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Samantha Lane. The network helps show where Samantha Lane may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Samantha Lane, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 1 | |
| 2 | 2025 | 0 | |
| 3 | 2025 | 3 | |
| 4 | 2024 | 0 | |
| 5 | 2024 | 0 | |
| 6 | 2024 | 1 | |
| 7 | 2022 | 46 | |
| 8 | 2022 | 12 | |
| 9 | 2022 | 3 | |
| 10 | 2022 | 1 | |
| 11 | 2021 | 1 | |
| 12 | 2020 | 43 | |
| 13 | 2020 | 7 | |
| 14 | 2018 | 19 | |
| 15 | Hemophagocytic lymphohistiocytosis (HLH) in a 25-year-old presenting with multisystem organ failure. | 2014 | 3 |
| 16 | 2013 | 1 | |
| 17 | 2012 | 15 | |
| 18 | 2009 | 10 | |
| 19 | Trade Mark Legislation and the Pharmaceutical Industry | 1999 | 1 |
| 20 | A Review of its Pharmacological Properties and Clinical Efficacy in the Treatment of Allergic Disorders | 1996 | 9 |
About Samantha Lane
Samantha Lane is a scholar working on Toxicology, Applied Microbiology and Biotechnology, Infectious Diseases, Pharmacology and Critical Care and Intensive Care Medicine, having authored 22 papers that have together received 185 indexed citations. Recurring topics across this work include SARS-CoV-2 and COVID-19 Research (7 papers), Pharmacovigilance and Adverse Drug Reactions (6 papers), Heparin-Induced Thrombocytopenia and Thrombosis (3 papers), Drug-Induced Adverse Reactions (3 papers), Viral Infections and Immunology Research (3 papers), COVID-19 Clinical Research Studies (2 papers), Health Systems, Economic Evaluations, Quality of Life (2 papers) and Pharmaceutical Economics and Policy (2 papers). The work is most often cited by research in Toxicology (22 citations), Infectious Diseases (97 citations), Applied Microbiology and Biotechnology (6 citations), Cardiology and Cardiovascular Medicine (45 citations) and Critical Care and Intensive Care Medicine (7 citations). Samantha Lane has collaborated with scholars based in United Kingdom, United States and Netherlands. Frequent co-authors include Saad Shakir, Alison Yeomans, Alison Evans, Vicki Osborne, Debabrata Roy, Rod Stables, Josephine A. Wright, Patrick McHugh, David R. Brown and Bashir M. Matata. Their work appears in journals such as BMJ Open, Drug Safety, Health Technology Assessment, Pharmacoepidemiology and Drug Safety and Journal of Viral Hepatitis.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.